Centiva Capital’s Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFNT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-40,000
Closed -$10K 1937
2022
Q2
$10K Hold
40,000
﹤0.01% 1541
2022
Q1
$14K Buy
+40,000
New +$17.5K ﹤0.01% 1515

Other funds holding NFNT.WS

Centiva Capital's NFNT.WS Position: Q3 2022 in Review

Centiva Capital sold out of Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFNT.WS) in Q3 2022, closing a stake of 40,000 shares — an estimated $10K sold.

Centiva Capital first reported a position in NFNT.WS in Q1 2022 and held it in 2 quarters. The position peaked at $14K in Q1 2022. 40 funds tracked by Wall St. Rank hold NFNT.WS as of Q3 2022.

  • Centiva Capital reported no remaining Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Centiva Capital sold 40,000 Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $10K.
  • Centiva Capital first reported a position in Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Centiva Capital's Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $14K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.